Designing immune responses with genetic immunization and immunostimulatory DNA sequences

Endocrine Regulations

Volumn 35, Issue 3, 2001, Pages 143-166

  Thalhamer, Josef ^a   Leitner, Wolfgang ^b   Hammerl, Peter ^a   Brtko, Julius ^c  

^a UNIVERSITY OF SALZBURG   (Austria)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; DNA VACCINE; EPITOPE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLASMID DNA; RETINOIC ACID RECEPTOR; THYROXINE DEIODINASE; TUMOR NECROSIS FACTOR ALPHA;

CELLULAR IMMUNITY; CPG ISLAND; DENDRITIC CELL; DNA SEQUENCE; GENE TARGETING; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; MACROPHAGE; NATURAL KILLER CELL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY FORMATION; COMMUNICABLE DISEASES; CPG ISLANDS; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; IODIDE PEROXIDASE; RECEPTORS, RETINOIC ACID; VACCINES, DNA;

EID: 0034787727     PISSN: 12100668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (183)

1. ABERLE JH, ABERLE SW, ALLISON SL, STIASNY K, ECKER M, MANDL CW, BERGER R, HEINZ FX: A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J Immunol 163, 6756-6761, 1999
2. ABRAMS SI, HAND PH, TSANG KY, SCHLOM J: Mutant ras epitopes as targets for cancer vaccines. Semin Oncol 23, 118-134, 1996
3. ABRAMS SI, STANZIALE SF, LUNIN SD, ZAREMBA S, SCHLOM J: Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses. Eur J Immunol 26, 435-443, 1996
4. ADERKA D: Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications. Isr J Med Sci 27, 52-60, 1991
5. AGADJANYAN MG, TRIVEDI NN, KUDCHODKAR S, BENNETT M, LEVINE W, LIN A, BOYER J, LEVY D, UGEN KE, KIM JJ, WEINER DB: An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV. AIDS Res Hum Retroviruses 13, 1561-1572, 1997
6. ANDRE S, SEED B, EBERLE J, SCHRAUT W, BULTMANN A, HAAS J: Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 72, 1497-1503, 1998
7. ANGUS CW, KLIVINGTON D, WYMAN J, KOVACS JA: Nucleic acid vaccination against Toxoplasma gondii in mice. J Eukaryot Microbiol 43, 117S, 1996
8. AOUDJIT F, BOSSE M, STRATOWA C, VORABERGER G, AUDETTE M: Regulation of intercellular adhesion molecule-1 expression by retinoic acid: analysis of the 5′ regulatory region of the gene. Int J Cancer 58, 543-549., 1994
9. AOUDJIT F, BROCHU N, MORIN N, POULIN G, STRATOWA C, AUDETTE M: Heterodimeric retinoic acid receptor-beta and retinoid X receptor-alpha complexes stimulate expression of the intercellular adhesion molecule-1 gene. Cell Growth Differ 6,515-521., 1995
10. AUF DEM BRINKE D, HESCH RD, KOHRLE J: Re-examination of the subcellular localization of thyroxine 5′-deiodination in rat liver. Biochem J 180,273-279, 1979
11. BABINA M, MAMMERI K, HENZ BM: Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion - evidence for retinoid signaling pathways in the mast cell lineage. J Leukoc Biol 69, 361-372., 2001
12. BAJ G, ARNULFO A, DEAGLIO S, TIBALDI E, SURICO N, MALAVASI F: All-trans retinoic acid inhibits the growth of breast cancer cells by up-regulating ICAM-1 expression. J Biol Regul Homeost Agents 13, 115-122., 1999
13. BALLAS ZK, RASMUSSEN WL, KRIEG AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157, 1840-1845, 1996
14. BALLOW M, XIANG S, GREENBERG SJ, BRODSKY L, ALLEN C, RICH G: Retinoic acid-induced modulation of IL-2 mRNA production and IL-2 receptor expression on T cells. Int Arch Allergy Immunol 113, 167-169., 1997
15. BANCHEREAU J, BRIERE F, CAUX C, DAVOUST J, LEBECQUE S, LIU YJ, PULENDRAN B, PALUCKA K: Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811, 2000
16. BARRY MA, JOHNSTON SA: Biological features of genetic immunization. Vaccine 15, 788-791, 1997
17. BARRY MA, LAI WC, JOHNSTON SA: Protection against mycoplasma infection using expression-library immunization. Nature 377, 632-635, 1995
18. BASSI V, VITALE M, FELICIELLO A, DE RIU S, ROSSI G, FENZI G: Retinoic acid induces intercellular adhesion molecule-1 hyperexpression in human thyroid carcinoma cell lines. J Clin Endocrinol Metab 80, 1129-1135., 1995
19. BENNETT AM, PHILLPOTTS RJ, PERKINS SD, JACOBS SC, WILLIAMSON ED: Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Vaccine 18, 588-596, 1999
20. BEUTLER B, CERAMI A: Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation. Immunol Res 5, 281-293, 1986
21. BOEHM U, KLAMP T, GROOT M, HOWARD JC: Cellular responses to interferon-gamma. Annu Rev Immunol 15, 749-795, 1997
22. BOISE LH, MINN AJ, NOEL PJ, JUNE CH, ACCAVITTI MA, LINDSTEN T, THOMPSON CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3, 87-98, 1995
23. BOURNE N, STANBERRY LR, BERNSTEIN DI, LEW D: DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 173, 800-807, 1996
24. BOYLE JS, KONIARAS C, LEW AM: Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 9, 1897-1906, 1997
25. BRISTOL JA, ORSINI C, LINDINGER P, THALHAMER J, ABRAMS SI: Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization [In Process Citation]. Cell Immunol 205, 73-83, 2000
26. BRTKO J, HARTL A, WEISS R, BERNHAUPT A, SCHEIBLHOFER S, MOSTBOCK S, THALHAMER J: DNA immunization in vivo down-regulates nuclear all-trans retinoic acid receptors in mouse spleen cells. Mol Cell Endocrinol 165, 107-113., 2000
27. BRTKO J, HARTL A, WEISS R, SCHEIBLHOFER S, MOSTBOECK S, THALHAMER J: Retinoic acid receptor status in mouse spleen during a primary immune response against beta-galactosidase. Endocr Regul 34, 113-118., 2000
28. BRTKO J, MOSTBOCK S, SCHEIBLHOFER S, HARTL A, THALHAMER J: DNA immunization is associated with increased activity of type I iodothyronine 5′-deiodinase in mouse liver. Mol Cell Endocrinol 152, 85-89., 1999
29. BUELER H, MULLIGAN RC: Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol Med 2, 545-555, 1996
30. BUSCH W: Verhandlungen ärztlicher Gesellschaften. Berliner Klin. Wochenschrift 23, 245-246, 1866
31. CARDON LR, BURGE C, CLAYTON DA, KARLIN S: Pervasive CpG suppression in animal mitochondrial genomes. Proc Natl Acad Sci U S A 91, 3799-3803, 1994
32. CARSWELL EA, OLD LJ, KASSEL RL, GREEN S, FIORE N, WILLIAMSON B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72, 3666-3670, 1975
33. CELLA M, SALLUSTO F, LANZAVECCHIA A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9, 10-16, 1997
34. CHACE JH, HOOKER NA, MILDENSTEIN KL, KRIEG AM, COWDERY JS: Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 84, 185-193, 1997
35. CHANG SW, Bu J, ROMPATO G, GARMENDIA AE: A vector DNA vaccine encoding pseudorabies virus immediate early protein demonstrates partial protection in mice against lethal virus challenge. Viral Immunol 11, 27-36, 1998
36. CHOW YH, CHIANG BL, LEE YL, CHI WK, LIN WC, CHEN YT, TAO MH: Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 160, 1320-1329, 1998
37. CHOW YH, HUANG WL, CHI WK, CHU YD, TAO MH: Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 71, 169-178, 1997
38. CIERNIK IF, BERZOFSKY JA, CARBONE DP: Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J Immunol 156, 2369-2375, 1996
39. CIPPITELLI M, YE J, VIGGIANO V, SICA A, GHOSH P, GULINO A, SANTONI A, YOUNG HA: Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter. J Biol Chem 271, 26783-26793., 1996
40. COLEY W: Treatment of inoperable malignant tumors with the toxins of Erysipelas and the bacillus Prodigiosus. Am J Med Sci 108, 183, 1894
41. CONRY RM, LOBUGLIO AF, LOECHEL F, MOORE SE, SUMEREL LA, BARLOW DL, CURIEL DT: A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther 2, 59-65, 1995
42. CORR M, LEE DJ, CARSON DA, TIGHE H: Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184, 1555-1560, 1996
43. CORR M, TIGHE H, LEE D, DUDLER J, TRIEU M, BRINSON DC, CARSON DA: Costimulation provided by DNA immunization enhances antitumor immunity. J Immunol 159, 4999-5004, 1997
44. COWDERY JS, BOERTH NJ, NORIAN LA, MYUNG PS, KORETZKY GA: Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J Immunol 162, 6770-6775, 1999
45. COWDERY JS, CHACE JH, YI AK, KRIEG AM: Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 156, 4570-4575, 1996
46. DAVIES PH, SHEPPARD MC, FRANKLYN JA: Inflammatory cytokines and type 15′-deiodinase expression in phil rat liver cells. Mol Cell Endocrinol 129, 191-198, 1997
47. DE GRAZIA U, FELLI MP, VACCA A, FARINA AR, MARODER M, CAPPABIANCA L, MECO D, FARINA M, SCREPAOTI I, FRATI L, ET AL.: Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor. J Exp Med 180, 1485-1497., 1994
48. DE WAAL MALEFYT R: The role of type I interferons in the differentiation and function of Th1 and Th2 cells. Semin Oncol 24, S9-94-S99-98, 1997
49. DOE B, SELBY M, BARNETT S, BAENZIGER J, WALKER CM: Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci U S A 93, 8578-8583, 1996
50. FEARON DT, CARTER RH: The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 13, 127-149, 1995
51. FELTQUATE DM, HEANEY S, WEBSTER RG, ROBINSON HL: Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158, 2278-2284, 1997
52. FENSTERLE J, GRODE L, HESS J, KAUFMANN SH: Effective DNA vaccination against listeriosis by prime/ boost inoculation with the gene gun. J Immunol 163, 4510-4518, 1999
53. FONG L, ENGLEMAN EG: Dendritic cells in cancer immunotherapy. Annu Rev Immunol 18, 245-273, 2000
54. FRASER IP, KOZIEL H, EZEKOWITZ RA: The serum mannosebinding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity. Semin Immunol 10, 363-372, 1998
55. FRIEDMAN A, HALEVY O, SCHRIFT M, ARAZI Y, SKLAN D: Retinoic acid promotes proliferation and induces expression of retinoic acid receptor-alpha gene in murine T lymphocytes. Cell Immunol 152, 240-248., 1993
56. Fu TM, GUAN L, FRIEDMAN A, ULMER JB, LIU MA, DONNELLY JJ: Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitininfluenza virus nucleoprotein fusion antigens. Vaccine 16, p1711-1717, 1998
57. Fu TM, ULMER JB, CAULFIELD MJ, DECK RR, FRIEDMAN A, WANG S, LIU X, DONNELLY JJ, LIU MA: Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 3, 362-371, 1997
58. GEISSLER M, GESIEN A, TOKUSHIGE K, WANDS JR: Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 158, 1231-1237, 1997
59. GILKESON GS, RUIZ P, PIPPEN AM, ALEXANDER AL, LEFKOWITH JB, PISETSKY DS: Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med 183, 1389-1397, 1996
60. GONZALEZ ARMAS JC, MORELLO CS, CRANMER LD, SPECTOR DH: DNA immunization confers protection against murine cytomegalovirus infection. J Virol 70, 7921-7928, 1996
61. GREENSFELDER L: Infectious diseases. Polio outbreak raises questions about vaccine. Science 290, 1867-1869., 2000
62. GUDAS LJ: Retinoids and vertebrate development. J Biol Chem 269, 15399-15402., 1994
63. HACKER H, MISCHAK H, MIETHKE T, LIPTAY S, SCHMID R, SPARWASSER T, HEEG K, LIPFORD GB, WAGNER H: CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. Embo J 17, 6230-6240, 1998
64. HACKER H, VABULAS RM, TAKEUCHI O, HOSHIKO K, AKIRA S, WAGNER H: Immune Cell Activation by Bacterial CpG-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor ReceptorAssociated Factor (TRAF)6. J Exp Med 192, 595-600, 2000
65. HANKE T, SCHNEIDER J, GILBERT SC, HILL AVS, MCMICHAEL A: DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine 16, 426-435, 1998
66. HARTL A, KIESSLICH J, WEISS R, BERNHAUPT A, MOSTBOCK S, SCHEIBLHOFER S, EBNER C, FERREIRA F, THALHAMER J: Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J Allergy Clin Immunol 103, 107-113, 1999
67. HARTL A, KIESSLICH J, WEISS R, BERNHAUPT A, MOSTBOCK S, SCHEIBLHOFER S, FLOCKNER H, SIPPL M, EBNER C, FERREIRA F, THALHAMER J: Isoforms of the major allergen of birch pollen induce different immune responses after genetic immunization. Int Arch Allergy Immunol 120, 17-29, 1999
68. HARTMANN G, KRIEG AM: Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164, 944-953, 2000
69. HARWIX S, ANDREESEN R, FERBER E, SCHWAMBERGER G: Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-alpha and reactive nitrogen intermediates. Res Immunol 143, 89-94, 1992
70. HEATH WR, CARBONE FR: Cytotoxic T lymphocyte activa-tion by cross-priming. Curr Opin Immunol 11, 314-318, 1999
71. HEMMI H, TAKEUCHI O, KAWAI T, KAISHO T, SATO S, SANJO H, MATSUMOTO M, HOSHINO K, WAGNER H, TAKEDA K, AKIRA S: A Toll-like receptor recognizes bacterial DNA.[In Process Citation]. Nature 408, 740-745, 2000
72. HORSPOOL JH, PERRIN PJ, WOODCOCK JB, Cox JH, KING CL, JUNE CH, HARLAN DM, ST. Louis DC, LEE KP: Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. J Immunol 160, 2706-2714, 1998
73. Hsu CH, CHUA KY, TAO MH, LAI YL, WU HD, HUANG SK, HSIEH KH: Immunoprophylaxis of allergeninduced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization [see comments]. Nat Med 2, 540-544, 1996
74. Hsu SC, OBEID OE, COLLINS M, IQBAL M, CHARGELEGUE D, STEWARD MW: Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: Involvement of IFN gamma. Int Immunol 10, 1441-1447, 1998
75. INCHAUSPE G, VITVITSKI L, MAJOR ME, JUNG G, SPENGLER U, MAISONNAS M, TREPO C: Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: Comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol 16, 185-195, 1997
76. IRVINE KR, RAO JB, ROSENBERG SA, RESTIFO NP: Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 156, 238-245, 1996
77. IWASAKI A, BARBER BH: Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope- expressing tumor. Cancer Immunol Immunother 45, 273-279, 1998
78. IWASAKI A, STIERNHOLM BJ, CHAN AK, BERINSTEIN NL, BARBER BH: Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158, 4591-4601, 1997
79. IWASAKI A, TORRES CA, OHASHI PS, ROBINSON HL, BARBER BH: The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 159, 11-14, 1997
80. JIAO S, WILLIAMS P, BERG RK, HODGEMAN BA, LIU L, REPETTO G, WOLFF JA: Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 3, 21-33., 1992
81. KAMATH AT, HANKE T, BRISCOE H, BRITTON WJ: Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis. Immunology 96, 511-516, 1999
82. KATSUMI A, EMI N, ABE A, HASEGAWA Y, ITO M, SAITO H: Humoral and cellular immunity to an encoded protein induced by direct DNA injection. Hum Gene Ther 5, 1335-1339., 1994
83. KIM JJ, AYYAVOO V, BAGARAZZI ML, CHATTERGOON MA, DANG K, WANG B, BOYER JD, WEINER DB: In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 158, 816-826, 1997
84. KIM JJ, BAGARAZZI ML, TRIVEDI N, HU Y, KAZAHAYA K, WILSON DM, CICCARELLI R, CHATTERGOON MA, DANG K, MAHALINGAM S, CHALIAN AA, AGADJANYAN MG, BOYER JD, WANG B, WEINER DB: Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat Biotechnol 15, 641-646, 1997
85. KIM JJ, NOTTINGHAM LK, TSAI A, LEE DJ, MAGUIRE HC, OH J, DENTCHEV T, MANSON KH, WYAND MS, AGADJANYAN MG, UGEN KE, WEINER DB: Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants. J Med Primatol 28, 214-223, 1999
86. KIM JJ, TSAI A, NOTTINGHAM LK, MORRISON L, CUNNING DM, OH J, LEE DJ, DANG K, DENTCHEV T, CHALIAN AA, AGADJANYAN MG, WEINER DB: Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo. J Clin Invest 103, 869-877, 1999
87. KIM JJ, YANG JS, LEE DJ, WILSON DM, NOTTINGHAM LK, MORRISON L, TSAI A, OH J, DANG K, DENTCHEV T, AGADJANYAN MG, SIN JI, CHALIAN AA, WEINER DB: Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo [In Process Citation]. Hum Gene Ther 11, 305-321, 2000
88. KOBAYASHI H, HORNER AA, MARTIN-OROZCO E, RAZ E: Prepriming: a novel approach to DNA-based vaccination and immunomodulation [In Process Citation]. Springer Semin Immunopathol 22, 85-96, 2000
89. KOBAYASHI H, HORNER AA, TAKABAYASHI K, NGUYEN MD, HUANG E, CINMAN N, RAZ E: Immunostimulatory DNA pre-priming: a novel approach for prolonged Th1-biased immunity. Cell Immunol 198, 69-75, 1999
90. KOHRLE J: Thyroid hormone deiodination in target tissues - a regulatory role for the trace element selenium? Exp Clin Endocrinol 102, 63-89, 1994
91. KOHRLE J, SCHOMBURG L, DRESCHER S, FEKETE E, BAUER K: Rapid stimulation of type 15′-deiodinase in rat pituitaries by 3,3′,5-triiodo-L-thyronine. Mol Cell Endocrinol 108, 17-21., 1995
92. KRIEG AM: Direct immunologic activities of CpG DNA and implications for gene therapy. J Gene Med 1, 56-63, 1999
93. KRIEG AM, Wu T, WEERATNA R, EFLER SM, LOVEHOMAN L, YANG L, YI AK, SHORT D, DAVIS HL: Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA 95, 12631-12636, 1998
94. KRIEG AM, YI AK, MAISON S, WALDSCHMIDT TJ, BISHOP GA, TEASDALE R, KORETZKY GA, KLINMAN DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549, 1995
95. KUMARAGURU U, ROUSE RJD, NAIR SK, BRUCE BD, ROUSE BT: Involvement of an ATP-dependent peptide chaperone in cross- presentation after DNA immunization. J Immunol 165, 750-759, 2000
96. LE TP, COONAN KM, HEDSTROM RC, CHAROENVIT Y, SEDEGAH M, EPSTEIN JE, KUMAR S, WAKG R, DOOLAN DL, MAGUIRE JD, PARKER SE, HOBART P, NORMAN J, HUFFMAN SL: Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 18, 1893-1901., 2000
97. LEE SW, CHO JH, SUNG YC: Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene. J Virol 72, 8430-8436, 1998
98. LEITNER WW: Myth, menace or medical blessing?: The clinical potential and the problems of genetic vaccines. EMBO Rep 2, 168-170., 2001
99. LEITNER WW, SEGUIN MC, BALLOU WR, SEITZ JP, SCHULTZ AM, SHEEHY MJ, LYON JA: Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J Immunol 159, 6112-6119, 1997
100. LIU MA, MCCLEMENTS W, ULMER JB, SHIVER J, DONNELLY J: Immunization of non-human primates with DNA vaccines. Vaccine 15, 909-912., 1997
101. LODMELL DL, RAY NB, ULRICH JT, EWALT LC: DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A(MPL). Vaccine 18, 1059-1066, 2000
102. LOMO J, SMELAND EB, ULVEN S, NATARAJAN V, BLOMHOFF R, GANDHI U, DAWSON MI, BLOMHOFF HK: RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol 175, 68-77., 1998
103. LOWRIE DB, TASCON RE, COLSTON MJ, SILVA CL: Towards a DNA vaccine against tuberculosis. Vaccine 12, 1537-1540, 1994
104. Lu Z, YUAN L, ZHOU X, SOTOMAYOR E, LEVITSKY HI, PARDOLL DM: CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes. J Exp Med 191, 541-550, 2000
105. MACGREGOR RR, BOYER JD, UGEN KE, LACY KE, GLUCKMAN SJ, BAGARAZZI ML, CHATTERGOON MA, BAINE Y, HIGGINS TJ, CICCARELLI RB, CONEY LR, GINSBERG RS, WEINER DB: First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 178, 92-100., 1998
106. MAECKER HT, UMETSU DT, DEKRUYFF RH, LEVY S: Cytotoxic T cell responses to DNA vaccination: Dependence on antigen presentation via class II MHC. J Immunol 161, 6532-6536, 1998
107. MANICKAN E, ROUSE RJ, Yu Z, WIRE WS, ROUSE BT: Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol 155, 259-265, 1995
108. MATEO RB, REICHNER JS, ALBINA JE: NO is not sufficient to explain maximal cytotoxicity of tumoricidal macrophages against an NO-sensitive cell line. J Leukoc Biol 60, 245-252, 1996
109. MATZINGER P: Tolerance, danger, and the extended family. Annu Rev Immunol 12, 991-1045, 1994
110. MEUNIER L, BOHJANEN K, VOORHEES JJ, COOPER KD: Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. J Invest Dermatol 103, 775-779., 1994
111. MINCHEFF M, TCHAKAROV S, ZOUBAK S, LOUKINOV D, BOTEV C, ALTANKOVA I, GEORGIEV G, PETROV S, MERYMAN HT: Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial. Eur Urol 38, 208-217., 2000
112. MOR G, KLINMAN DM, SHAPIRO S, HAGIWARA E, SEDEGAH M, NORMAN JA, HUFFMAN SL, STEINBERG AD: Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol 155, 2039-2046, 1995
113. MOSMANN TR, COFFMAN RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145-173, 1989
114. NADERI S, BLOMHOFF HK: Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: regulation of cyclin E, cyclin A, and p21(Cipl). Blood 94, 1348-1358., 1999
115. NAGATA T, UCHIJIMA M, YOSHIDA A, KAWASHIMA M, KOIDE Y: Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem Biophys Res Commun 261, 445-451, 1999
116. NICHOLS WW, LEDWITH BJ, MANAM SV, TROILO PJ: Potential DNA vaccine integration into host cell genome. Ann N Y Acad Sci 772, 30-39., 1995
117. PETERSEN TR, BREGENHOLTA S, PEDERSEN LO, NISSEN MH, CLAESSON MH: Human p53(264-272) HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic mice. Cancer Lett 137, 183-191, 1999
118. PISETSKY DS, REICH CF, 3RD: Influence of backbone chemistry on immune activation by synthetic oligonucleotides. Biochem Pharmacol 58, 1981-1988, 1999
119. POHL J, LAFACE D, SANDS JF: Transcription of retinoic acid receptor genes in transgenic mice increases CD8 T-cell subset. Mol Biol Rep 17, 135-142., 1993
120. POLTORAK A, HE X, SMIRNOVA I, LIU MY, HUFFEL CV, DU X, BIRDWELL D, ALEJOS E, SILVA M, GALANOS C, FREUDENBERG M, RICCIARDI-CASTAGNOLI P, LAYTON B, BEUTLER B: Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088, 1998
121. PORGADOR A, IRVINE KR, IWASAKI A, BARBER BH, RESTIFO NP, GERMAIN RN: Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med 188, P1075-1082, 1998
122. PRAYAGA SK, FORD MJ, HAYNES JR: Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. Vaccine 15, 1349-1352, 1997
123. PUGIN J, HEUMANN ID, TOMASZ A, KRAVCHENKO VV, AKAMATSU Y, NISHIJIMA M, GLAUSER MP, TOBIAS PS, ULEVITCH RJ: CD14 is a pattern recognition receptor. Immunity 1, 509-516, 1994
124. RACKE MK, BURNETT D, PAK SH, ALBERT PS, CANNELLA B, RAINE CS, MCFARLIN DE, SCOTT DE: Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154, 450-458., 1995
125. RAZ E, CARSON DA, PARKER SE, PARR TB, ABAI AM, AICHINGER G, GROMKOWSKI SH, SINGH M, LEW D, YANKAUCKAS MA, ET AL.: Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A 91, 9519-9523, 1994
126. RAZ E, TIGHE H, SATO Y, CORR M, DUDLER JA, ROMAN M, SWAIN SL, SPIEGELBERG HL, CARSON DA: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A 93, 5141-5145, 1996
127. RIDGE JP, Di ROSA F, MATZINGER P: A conditioned dendritic cell can be a temporal bridge between a CD4+ T- helper and a T-killer cell [see comments]. Nature 393, 474-478, 1998
128. RODRIGUEZ F, ZHANG J, WHITTON JL: DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J Virol 71, 8497-8503, 1997
129. Ross TM, Xu Y, BRIGHT RA, ROBINSON HL: C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nature Immunol 1, 127-131, 2000
130. ROY MJ, WU MS, BARR LJ, FULLER JT, TUSSEY LG, SPELLER S, CULP J, BURKHOLDER JK, SWAIN WF, DIXON RM, WIDERA G, VESSEY R, KING A, OGG G, GALLIMORE A, HAYNES JR, HEYDENBURG FULLER D: Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19, 764-778., 2000
131. SATO Y, ROMAN M, TIGHE H, LEE D, CORR M, NGUYEN MD, SILVERMAN GJ, LOTZ M, CARSON DA, RAZ E: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354, 1996
132. SCHEIBLHOFER S, CHEN D, WEISS R, KHAN F, MOSTBÖCK S, FEGEDING K, LEITNER WW, THALHAMER J, LYON JA: Removal of the circumsporozoite protein glycophosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection. Eur J Immunol (in press), 2001
133. SCHWAMBERGER G, FLESCH I, FERBER E: Characterization and partial purification of a high molecular weight tumoricidal activity secreted by murine bone marrow macrophages. Int Immunol 4, 253-264, 1992
134. SCHWANDNER R, DZIARSKI R, WESCHE H, ROTHE M, KIRSCHNING CJ: Peptidoglycan- and lipoteichoic acidinduced cell activation is mediated by toll-like receptor 2. J Biol Chem 274, 17406-17409, 1999
135. SEDEGAH M, HEDSTROM R, HOBART P, HUFFMAN SL: Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci U S A 91, 9866-9870, 1994
136. SEGAL BM, KLINMAN DM, SHEVACH EM: Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol 158, 5087-5090, 1997
137. SHIVER JW, PERRY HC, DAVIES ME, FREED DC, LIU MA: Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination. Ann N Y Acad Sci 772, 198-208, 1995
138. SIN JI, KIM JJ, UGEN KE, CICCARELLI RB, HIGGINS TJ, WEINER DB: Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur J Immunol 28, p3530-3540, 1998
139. SPARWASSER T, KOCH ES, VABULAS RM, HEEG K, LIPFORD GB, ELLWART JW, WAGNER H: Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 28, 2045-2054, 1998
140. SPARWASSER T, MIETHKE T, LIPFORD G, BORSCHERT K, HACKER H, HEEG K, WAGNER H: Bacterial DNA causes septic shock [letter]. Nature 386, 336-337, 1997a
141. SPARWASSER T, MIETHKE T, LIPFORD G, ERDMANN A, HACKER H, HEEG K, WAGNER H: Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 27, 1671-1679, 1997b
142. STACEY KJ, SWEET MJ, HUME DA: Macrophages ingest and are activated by bacterial DNA. J Immunol 157, 2116-2122, 1996
143. STAN AC, CASARES S, BRUMEANU TD, KLINMAN DM, BONA CA: CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes. Eur J Immunol 31, 301-310., 2001
144. STEINMAN RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9, 271-296, 1991
145. SUN S, ZHANG X, TOUGH DF, SPRENT J: Type I interferonmediated stimulation of T cells by CpG DNA. J Exp Med 188, 2335-2342, 1998
146. SWEET MJ, STACEY KJ, KAKUDA DK, MARKOVICH D, HUME DA: IFN-gamma primes macrophage responses to bacterial DNA. J Interferon Cytokine Res 18, 263-271, 1998
147. SZABO G, PUPPOLO M, VERMA B, CATALANO D: Regulatory potential of ethanol and retinoic acid on human monocyte functions. Alcohol Clin Exp Res 18, 548-554., 1994
148. SZONDY Z, LECOEUR H, FESUS L, GOUGEON ML: All-trans retinoic acid inhibition of anti-CD3-induced T cell apoptosis in human immunodeficiency virus infection mostly concerns CD4 T lymphocytes and is mediated via regulation of CD95 ligand expression. J Infect Dis 178, 1288-1298., 1998
149. TACKET CO, ROY MJ, WIDERA G, SWAIN WF, BROOME S, EDELMAN R: Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 17, 2826-2829., 1999
150. TANG DC, DEVIT M, JOHNSTON SA: Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154, 1992
151. TANGHE A, DENIS O, LAMBRECHT B, MOTTE V, VANDENBERG T, HUYEN K: Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infec Immunity 68, 3854-3860, 2000
152. THOMSON SA, SHERRITT MA, MEDVECZKY J, ELLIOTT SL, Moss DJ, FERNANDO GJ, BROWN LE, SUHRBIER A: Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J Immunol 160, 1717-1723, 1998
153. TOKUNAGA T, YAMAMOTO H, SHIMADA S, ABE H, FUKUDA T, FUJISAWA Y, FURUTANI Y, YANO O, KATAOKA T, SUDO T, ET AL.: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 72, 955-962, 1984
154. TUTING T, GAMBOTTO A, ROBBINS PD, STORKUS WJ, DELEO AB: Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth Ap53 tumor-specific antigen. Gene Ther 6, 629-636, 1999
155. UCHIJIMA M, YOSHIDA A, NAGATA T, KOIDE Y: Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol 161, p5594-5599, 1998
156. ULMER JB, DECK RR, DEWITT CM, DONNHLY JI, LIU MA: Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89, 59-67, 1996
157. ULMER JB, DONNELLY JJ, PARKER SE, RHODES GH, FELGNER PL, DWARKI VJ, GROMKOWSKI SH, DECK RR, DEWITT CM, FRIEDMAN A, ET AL.: Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science 259, 1745-1749, 1993
158. UNDERHILL DM, OZINSKY A, SMITH KD, ADEREM A: Tolllike receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A 96, 14459-14463, 1999
159. VELAZ-FAIRCLOTH M, COBB AJ, HORSTMAN AL, HENRY SC, FROTHIKGHAM R: Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein. Infect Immun 67, 4243-4250, 1999
160. VIDALIN O, TANAKA E, SPENGLER U, TREPO C, INCHAUSPE G: Targeting of hepatitis C virus core protein for MHCI or MHCII presentation does not enhance induction of immune responses to DNA vaccination. DNA Cell Biol 18, 611-621, 1999
161. VINNER L, NIELSEN HV, BRYDER K, CORBET S, NIELSEN C, FOMSGAARD A: Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons. Vaccine 17, 2166-2175, 1999
162. WANG B, MERVA M, DANG K, UGEN KE, WILLIAMS WV, WEINER DB: Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Hum Gene Ther 6, 407-418, 1995
163. WANG B, UGEN KE, SRIKANTAN V, AGADJANYAN MG, DANG K, REFAELI Y, SATO AI, BOYER J, WILLIAMS WV, WEINER DB: Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 90, 4156-4160, 1993
164. WATANABE A, RAZ E, KOHSAKA H, TIGHE H, BAIRD SM, KIPPS TJ, CARSON DA: Induction of antibodies to a kappa V region by gene immunization. J Immunol 151, 2871-2876, 1993
165. WEISS R, DURNBERGER J, MOSTBOCK S, SCHEIBLHOFER S, HARTL A, BREITENBACH M, STRASSER P, DORNER F, LIVEY I, CROWE B, THALHAMER J: Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine 18, 815-824, 1999
166. WEISS R, LEITNER WW, SCHEIBLHOFER S, CHEN D, BERNHAUPT A, MOSTBOCK S, THALHAMER J, LYON JA: Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the plasmodium berghei circumsporozoite protein [In Process Citation]. Infect Immun 68, 5914-5919, 2000
167. WILD J, GRUSBY MJ, SCHIRMBECK R, REIMANN J: Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. J Immunol 163, 1880-1887, 1999
168. WOLFF JA, LUDTKE JJ, ACSADI G, WILLIAMS P, JAM A: Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1, 363-369, 1992
169. WOLFF JA, MALONE RW, WILLIAMS P, CHONG W, ACSADI G, JANI A, FELGNER PL: Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468, 1990
170. WORM M, KRAH JM, MANZ RA, HENZ BM: Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro. Blood 92, 1713-1720., 1998
171. WU Y, KIPPS TJ: Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome- dependent degradation are highly efficient inducers of cytolytic T lymphocytes. J Immunol 159, 6037-6043, 1997
172. XIANG ZQ, SPITALNIK S, TRAN M, WUNNER WH, CHENG J, ERTL HC: Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132-140, 1994
173. XIANG ZQ, SPITALNIK SL, CHENG J, ERIKSON J, WOJCZYK B, ERTL HC: Immune responses to nucleic acid vaccines to rabies virus. Virology 209, 569-579, 1995
174. XU D, LIEW FY: Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84, 173-176, 1995
175. XU L, SANCHEZ A, YANG Z, ZAKI SR, NABEL EG, NICHOL ST, NABEL GJ: Immunization for Ebola virus infection. Nat Med 4, p37-42, 1998
176. YAMAMOTO S, KURAMOTO E, SHIMADA S, TOKUNAGA T: In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 79, 866-873, 1988
177. YANG Y, MINUCCI S, ZAND DJ, OZATO K, ASHWELL JD: T cell activation and increases in protein kinase C activity enhance retinoic acid-induced gene transcription. Mol Endocrinol 8, 1370-1376., 1994
178. YANKAUCKAS MA, MORROW JE, PARKER SE, ABAI A, RHODES GH, DWARKI VJ, GROMKOWSKI SH: Long-term antinucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol 12, 771-776, 1993
179. YI AK, KRIEG AM: CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J Immunol 160, 1240-1245, 1998
180. Yi AK, KRIEG AM: Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 161, 4493-4497, 1998
181. YOSHIDA A, NAGATA T, UCHIJIMA M, HIGASHI T, KOIDE Y: Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine 18, 1725-1729, 2000
182. Yu ZY, KAREM KL, KANANGAT S, MANICKAN E, ROUSE BT: Protection by minigenes: a novel approach of DNA vaccines. Vaccine 16, 1660-1667, 1998
183. ZUR MEGEDE J, CHEN MC, DOE B, SCHAEFER M, GREER CE, SELBY M, OTTEN GR, BARNETT SW: Increased expression and immunogenicity of sequence-modified human immunodeficiency virus